Chinese herbal medicine treatment and the association with long-term major adverse cardiac events in patients with chronic kidney disease: A propensity-score matched cohort study

The use of CHM as an adjunct therapy in CKD patients was associated with a significantly lower risk of MACEs and all-cause mortality. These findings support the potential of CHM in cardiovascular risk mitigation among CKD patients and highlight the need for future clinical and ethnopharmacological investigations.